Inpefa 400 MG Oral Tablet
- RxCUI
- 2638693
- RxNorm name
- Inpefa 400 MG Oral Tablet
- Display name
- Inpefa 400 MG Oral Tablet
- Full name
- Inpefa 400 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INPEFA | SOTAGLIFLOZIN | Lexicon Pharmaceuticals, Inc. | 1a46614e-05f6-421a-b6f4-d6f8760d643a | 2026-01-29 | Warnings, Adverse reactions | 2638693 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a46614e-05f6-421a-b6f4-d6f8760d643a | Inpefa 400 MG Oral Tablet | SY | 10 | These highlights do not include all the information needed to use INPEFA safely and effectively. See full prescribing information for INPEFA. INPEFA ® (sotagliflozin) tablets, for oral use Initial U.S. Approval: 2023 | 20260129 |
| 1a46614e-05f6-421a-b6f4-d6f8760d643a | inpefa 400 MG Oral Tablet | PSN | 10 | These highlights do not include all the information needed to use INPEFA safely and effectively. See full prescribing information for INPEFA. INPEFA ® (sotagliflozin) tablets, for oral use Initial U.S. Approval: 2023 | 20260129 |
| 1a46614e-05f6-421a-b6f4-d6f8760d643a | sotagliflozin 400 MG Oral Tablet [Inpefa] | SBD | 10 | These highlights do not include all the information needed to use INPEFA safely and effectively. See full prescribing information for INPEFA. INPEFA ® (sotagliflozin) tablets, for oral use Initial U.S. Approval: 2023 | 20260129 |